FI863848A7 - Vaccines and immunoassays for acquired immunodeficiency syndrome (AIDS) - Google Patents

Vaccines and immunoassays for acquired immunodeficiency syndrome (AIDS) Download PDF

Info

Publication number: FI863848A7
Authority: FI; Finland
Prior art keywords: immunoassays; vaccines; aids; acquired immunodeficiency; immunodeficiency syndrome
Prior art date: 1985-09-25

Application number

FI863848A

Other languages

Finnish (fi)

Swedish (sv)

Other versions

FI863848L (en

FI863848A0 (en

Inventor

Shiu-Lok Hu

Linda Madisen

Anthony F Purchio

Original Assignee

Oncogen

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1985-09-25

Filing date

1986-09-24

Publication date

1987-03-26

1986-09-24 Application filed by Oncogen filed Critical Oncogen

1986-09-24 Publication of FI863848A0 publication Critical patent/FI863848A0/en

1987-03-26 Publication of FI863848L publication Critical patent/FI863848L/en

1987-03-26 Publication of FI863848A7 publication Critical patent/FI863848A7/en

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
- C12N2710/14141—Use of virus, viral particle or viral elements as a vector
- C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
- C12N2710/24141—Use of virus, viral particle or viral elements as a vector
- C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
- C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
- C12N2740/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Genetics & Genomics (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Biophysics (AREA)
Bioinformatics & Cheminformatics (AREA)
Biochemistry (AREA)
Zoology (AREA)
Molecular Biology (AREA)
Wood Science & Technology (AREA)
General Health & Medical Sciences (AREA)
General Engineering & Computer Science (AREA)
Virology (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
Physics & Mathematics (AREA)
Plant Pathology (AREA)
Gastroenterology & Hepatology (AREA)
Microbiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicinal Chemistry (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

FI863848A 1985-09-25 1986-09-24 Vaccines and immunoassays for acquired immunodeficiency syndrome (AIDS) FI863848A7 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date
US77990985A	1985-09-25	1985-09-25
US84298486A	1986-03-27	1986-03-27
US90521786A	1986-09-09	1986-09-09

Publications (3)

Publication Number	Publication Date
FI863848A0 FI863848A0 (en)	1986-09-24
FI863848L FI863848L (en)	1987-03-26
FI863848A7 true FI863848A7 (en)	1987-03-26

Family

ID=27419757

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI863848A FI863848A7 (en)	1985-09-25	1986-09-24	Vaccines and immunoassays for acquired immunodeficiency syndrome (AIDS)

Country Status (22)

Country	Link
CN (1)	CN1020752C (en)
AT (1)	ATA256786A (en)
CH (1)	CH676247A5 (en)
DE (1)	DE3690508T1 (en)
DK (1)	DK455486A (en)
ES (2)	ES2002490A6 (en)
FI (1)	FI863848A7 (en)
FR (1)	FR2587720A2 (en)
GB (1)	GB2181435B (en)
GR (1)	GR862412B (en)
HU (1)	HU205780B (en)
IE (1)	IE59314B1 (en)
IL (1)	IL80073A (en)
IT (1)	IT1195829B (en)
MY (1)	MY103182A (en)
NL (1)	NL8602422A (en)
NO (1)	NO863803L (en)
NZ (1)	NZ217645A (en)
PT (1)	PT83434B (en)
SE (4)	SE8604007L (en)
WO (1)	WO1987002038A1 (en)
YU (1)	YU46753B (en)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0220234B1 (en) *	1985-04-08	1994-08-03	Genetic Systems Corporation	EXPRESSION AND DIAGNOSTIC USE OF gag ENCODED PEPTIDES WHICH ARE IMMUNOLOGICALLY REACTIVE WITH ANTIBODIES TO LAV
US4734362A (en) *	1986-02-03	1988-03-29	Cambridge Bioscience Corporation	Process for purifying recombinant proteins, and products thereof
US4925784A (en) *	1986-04-04	1990-05-15	Hoffmann-La Roche Inc.	Expression and purification of an HTLV-III gag/env gene protein
US4983387A (en) *	1986-05-19	1991-01-08	Viral Technologies Inc.	HIV related peptides, immunogenic antigens, and use therefor as subunit vaccine for AIDS virus
ATE107861T1 (en) *	1986-09-19	1994-07-15	Oncogen	USE OF ACTIVATED T-LYMPHOCYTES TO PREPARE A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF AIDS.
IL84154A0 (en) *	1986-10-16	1988-03-31	Microgenesys Inc	Polypeptides derived from the envelope gene of human immunodeficiency virus in recombinant baculovirus infected insect cells and vaccines against acquired immune deficiency syndrome containing the same
EP0272858A3 (en) *	1986-12-15	1989-07-12	Repligen Corporation	Recombinant hiv envelope proteins produced in insect cells
ES2104556T3 (en) *	1987-01-16	1997-10-16	Pasteur Institut	PEPTIDES THAT HAVE IMMUNOLOGICAL PROPERTIES OF HIV-2.
FR2610632B1 (en) *	1987-02-11	1990-12-21	Pasteur Institut	CHARACTERISTIC PEPTIDES OF HUMAN IMMUNODEFICIENCY RETROVIRUSES (HIV VIRUSES) THEIR APPLICATIONS IN THE DIAGNOSIS OF INFECTIONS DUE TO CERTAIN OF THESE VIRUSES AND, IF NECESSARY, IN VACCINATION AGAINST AIDS
US5681713A (en) *	1987-05-08	1997-10-28	Smithkline Beecham Corporation	Expression of heterologous proteins in Drosophila cells
GB8714802D0 (en) *	1987-06-24	1987-07-29	Proteus Biotech Ltd	Synthetic polypeptides
DE10399032I1 (en) *	1987-08-28	2004-01-29	Health Research Inc	Recombinant viruses.
FR2620030B1 (en) *	1987-09-07	1990-03-23	Transgene Sa	VECTOR FOR THE EXPRESSION OF PROTEINS OF HIV-2 VIRUS, A CAUSAL AGENT FOR AIDS, CELL CULTURE INFECTED OR TRANSFORMED THROUGH THIS VECTOR, PROTEINS OBTAINED, VACCINE AND ANTIBODIES OBTAINED
IL89118A0 (en) *	1988-02-03	1989-08-15	Microgenesys Inc	Vaccine containing polypeptides derived from the envelope gene of human immunodeficiency virus type 1
US5763160A (en) *	1988-02-12	1998-06-09	United Biomedical, Inc.	Synthetic peptides and process of using same for the detection of antibodies to human immunodeficiency virus (HIV) gp120 envelope protein, diagnosis of AIDS and pre-AIDS conditions and as vaccines
ES2059823T3 (en) *	1988-05-06	1994-11-16	Ferropas Ag	METHODS AND SYSTEMS FOR PRODUCING HIV ANTIGENS.
US5043262A (en) *	1988-05-12	1991-08-27	Dana Farber Cancer Institute	Protein, sequences containing the VPU gene therefore, vectors, methods of preparation and use
AP129A (en) *	1988-06-03	1991-04-17	Smithkline Biologicals S A	Expression of retrovirus gag protein eukaryotic cells
US5614404A (en) *	1988-06-10	1997-03-25	Theriod Biologics, Incorporated	Self-assembled, defective, non-self-propagating lentivirus particles
WO1989012095A1 (en) *	1988-06-10	1989-12-14	Applied Biotechnology, Inc.	A method of evaluating recombinant vaccines against immunodeficiency virus
US5631154A (en) *	1988-06-10	1997-05-20	Therion Biologics, Incorporated	Self assembled, defective, non-self-propagating lentivirus particles
US5747324A (en) *	1988-06-10	1998-05-05	Therion Biologics Corporation	Self-assembled, defective, non-self-propagating lentivirus particles
US5665577A (en) *	1989-02-06	1997-09-09	Dana-Farber Cancer Institute	Vectors containing HIV packaging sequences, packaging defective HIV vectors, and uses thereof
WO1990012880A1 (en) *	1989-04-18	1990-11-01	Applied Biotechnology, Inc.	Generation of hybrid genes and proteins by virus-mediated recombination
WO1990015141A2 (en) *	1989-06-01	1990-12-13	Applied Biotechnology, Inc.	Self-assembled, defective, non-self-propagating viral particles
GB8923123D0 (en)	1989-10-13	1989-11-29	Connaught Lab	A vaccine for human immunodeficiency virus
US5981276A (en) *	1990-06-20	1999-11-09	Dana-Farber Cancer Institute	Vectors containing HIV packaging sequences, packaging defective HIV vectors, and uses thereof
US5840312A (en) *	1991-05-02	1998-11-24	Institut Pasteur	Recombinant Bacillus anthracis strains unable to produce the lethal factor protein or edema factor protein
FR2676068B1 (en) *	1991-05-02	1994-11-04	Pasteur Institut	IMMUNOGENIC RECOMBINANT STRAINS OF B. ANTHRACIS - IMMUNOGENIC COMPOSITIONS CONTAINING THEM.
ATE219520T1 (en) *	1991-11-08	2002-07-15	Upjohn Co	VACCINE AGAINST FELINE LEUKEMIA VIRUS
CA2145418A1 (en)	1992-09-29	1994-04-14	John S. Patton	Pulmonary delivery of active fragments of parathyroid hormone
DE4405810A1 (en)	1994-02-23	1995-08-24	Behringwerke Ag	Peptides derived from a retrovirus from the HIV group and their use
WO1995024183A1 (en)	1994-03-07	1995-09-14	Inhale Therapeutic Systems	Methods and compositions for pulmonary delivery of insulin
AU5259796A (en)	1995-02-10	1996-08-27	Worcester Foundation For Biomedical Research, Inc.	Delivery of exogenous compounds
US6013506A (en) *	1995-06-05	2000-01-11	Wardley; Richard C.	Feline leukemia virus vaccines
EP0762212B1 (en) *	1995-09-06	2000-01-12	Schablonentechnik Kufstein Aktiengesellschaft	Process for making a printing screen
US6723558B1 (en)	1996-01-23	2004-04-20	St. Jude Children's Research Hospital	Preparation and use of viral vectors for mixed envelope protein vaccines against human immunodeficiency viruses
US5741492A (en) *	1996-01-23	1998-04-21	St. Jude Children's Research Hospital	Preparation and use of viral vectors for mixed envelope protein vaccines against human immunodeficiency viruses
US6565885B1 (en)	1997-09-29	2003-05-20	Inhale Therapeutic Systems, Inc.	Methods of spray drying pharmaceutical compositions
US6309623B1 (en)	1997-09-29	2001-10-30	Inhale Therapeutic Systems, Inc.	Stabilized preparations for use in metered dose inhalers
US20060165606A1 (en)	1997-09-29	2006-07-27	Nektar Therapeutics	Pulmonary delivery particles comprising water insoluble or crystalline active agents
US7871598B1 (en)	2000-05-10	2011-01-18	Novartis Ag	Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
ATE508735T1 (en)	2001-12-19	2011-05-15	Novartis Ag	PULMONARY ADMINISTRATION OF AMINOGLYCOSIDES

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0127839B1 (en) *	1983-05-27	1992-07-15	THE TEXAS A&M UNIVERSITY SYSTEM	Method for producing a recombinant baculovirus expression vector
US4662514A (en) *	1983-11-01	1987-05-05	Charleswater Products, Inc.	Electrically conductive polymeric tubes for static sensitive electronic devices
IL76082A (en) *	1984-08-22	1991-07-18	Us Health	Molecular clones of the genome of htlv-iii and a process for the preparation thereof
US9328391B1 (en) *	1984-08-22	2016-05-03	The United States Of America As Represented By The Secretary, Department Of Health And Human Services	Cloning and expression of HIV-1 DNA
ATE373010T1 (en) *	1984-10-18	2007-09-15	Pasteur Institut	GAG ANTIGEN AND ITS USE FOR DETECTING LAV INFECTION, AND IN IMMUNOGENIC COMPOSITIONS
GB8501473D0 (en) *	1985-01-21	1985-02-20	Pasteur Institut	Cloned dna sequences
CA1341482C (en) *	1984-10-31	2005-05-10	Paul A. Luciw	Process for preparing fragments of aids-associated retroviruses
AU600658B2 (en) *	1984-12-24	1990-08-23	Genentech Inc.	Molecularly cloned acquired immunodeficiency syndrome polypeptides and their methods of use
US4774175A (en) *	1985-03-01	1988-09-27	Centocor, Inc.	Immunochemical methods for the detection of antibody against HTLV-III
FI861626A7 (en) *	1985-04-19	1986-10-20	Hoffmann La Roche	FOERVAERVAT IMMUNBRIST SYNDROME (AIDS) -RELATERAT VIRALT RECOMBINANT HOELJEPROTEIN SAMT ETT TESTFOERFARANDE FOER AIDS.
FR2586427B1 (en) *	1985-08-20	1988-12-09	Pasteur Institut	NUCLEOTIDE AND POLYPEPTIDE SEQUENCES FROM VISNA VIRUS AND THEIR APPLICATION TO DIAGNOSTIC TESTS AND THE PRODUCTION OF IMMUNOGENIC COMPOSITIONS

1986
- 1986-09-22 NZ NZ217645A patent/NZ217645A/en unknown
- 1986-09-22 GR GR862412A patent/GR862412B/en unknown
- 1986-09-23 SE SE8604007A patent/SE8604007L/en not_active Application Discontinuation
- 1986-09-23 IE IE252586A patent/IE59314B1/en not_active IP Right Cessation
- 1986-09-24 DK DK455486A patent/DK455486A/en not_active Application Discontinuation
- 1986-09-24 HU HU864072A patent/HU205780B/en not_active IP Right Cessation
- 1986-09-24 NO NO863803A patent/NO863803L/en unknown
- 1986-09-24 FI FI863848A patent/FI863848A7/en not_active IP Right Cessation
- 1986-09-24 GB GB8622987A patent/GB2181435B/en not_active Expired - Fee Related
- 1986-09-24 CH CH3821/86A patent/CH676247A5/fr not_active IP Right Cessation
- 1986-09-24 IT IT67730/86A patent/IT1195829B/en active
- 1986-09-24 ES ES8602123A patent/ES2002490A6/en not_active Expired
- 1986-09-25 FR FR8613414A patent/FR2587720A2/en active Granted
- 1986-09-25 DE DE19863690508 patent/DE3690508T1/de not_active Withdrawn
- 1986-09-25 WO PCT/US1986/002002 patent/WO1987002038A1/en not_active Ceased
- 1986-09-25 YU YU165486A patent/YU46753B/en unknown
- 1986-09-25 CN CN86106632A patent/CN1020752C/en not_active Expired - Fee Related
- 1986-09-25 NL NL8602422A patent/NL8602422A/en not_active Application Discontinuation
- 1986-09-25 PT PT83434A patent/PT83434B/en not_active IP Right Cessation
- 1986-09-25 AT AT0256786A patent/ATA256786A/en unknown
- 1986-12-31 IL IL8007386A patent/IL80073A/en not_active IP Right Cessation
1987
- 1987-09-29 MY MYPI87002188A patent/MY103182A/en unknown
1988
- 1988-05-13 ES ES8801494A patent/ES2006941A6/en not_active Expired
1991
- 1991-10-14 SE SE9102976A patent/SE9102976L/en not_active Application Discontinuation
- 1991-10-14 SE SE9102974A patent/SE9102974L/en not_active Application Discontinuation
- 1991-10-14 SE SE9102975A patent/SE9102975L/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
MY103182A (en)	1993-05-29
SE8604007L (en)	1987-03-26
CN1020752C (en)	1993-05-19
CH676247A5 (en)	1990-12-28
ES2002490A6 (en)	1988-08-16
NL8602422A (en)	1987-04-16
GB2181435A (en)	1987-04-23
ATA256786A (en)	1995-05-15
GB8622987D0 (en)	1986-10-29
IE862525L (en)	1987-03-25
SE9102974D0 (en)	1991-10-14
GB2181435B (en)	1990-01-10
DK455486A (en)	1987-03-26
DK455486D0 (en)	1986-09-24
FR2587720B2 (en)	1995-02-10
ES2006941A6 (en)	1989-05-16
HU205780B (en)	1992-06-29
FI863848L (en)	1987-03-26
GR862412B (en)	1987-01-23
SE9102975L (en)	1993-04-15
IL80073A0 (en)	1986-12-31
DE3690508T1 (en)	1988-06-23
WO1987002038A1 (en)	1987-04-09
CN86106632A (en)	1987-05-13
YU165486A (en)	1989-08-31
FI863848A0 (en)	1986-09-24
PT83434B (en)	1988-07-29
YU46753B (en)	1994-05-10
HUT42133A (en)	1987-06-29
PT83434A (en)	1986-10-01
NZ217645A (en)	1991-11-26
FR2587720A2 (en)	1987-03-27
SE9102974L (en)	1993-04-15
IT1195829B (en)	1988-10-27
SE9102975D0 (en)	1991-10-14
SE9102976D0 (en)	1991-10-14
SE9102976L (en)	1993-04-15
NO863803D0 (en)	1986-09-24
IT8667730A0 (en)	1986-09-24
SE8604007D0 (en)	1986-09-23
IE59314B1 (en)	1994-02-09
NO863803L (en)	1987-03-26
IL80073A (en)	1995-01-24

Publication	Publication Date	Title
FI863848A7 (en)	1987-03-26	Vaccines and immunoassays for acquired immunodeficiency syndrome (AIDS)
FI871362A7 (en)	1987-03-27	Viral vaccine.
DE3752263D1 (en)	1999-04-29	Vaccines
DE3890874C5 (en)	2005-10-20	Recombinant viruses
FI870140A7 (en)	1987-01-14	Oral vaccines.
DK448987A (en)	1988-01-28	cyclone
DK354886D0 (en)	1986-07-25	microemulsion
DE3664308D1 (en)	1989-08-17	VACUUM SINGLE FILER
DK256488D0 (en)	1988-05-10	IMMUNO MODULATING PHARMACEUTICAL PREPARATION
FI885039A0 (en)	1988-11-01	Methods for the preparation of benanomicins A and B and dexylosylbenanomicin B.
DK403688A (en)	1988-07-19	cyclone
FR2608412B3 (en)	1993-09-10	VACUUM
DK62486D0 (en)	1986-02-07	VACCINE
DK62386D0 (en)	1986-02-07	VACCINE
FI885441A7 (en)	1988-11-23	New vaccines
FI863704A7 (en)	1986-09-12	Improvements regarding viral isolates and their use.
ES289765Y (en)	1986-11-16	CERAMIC STAIRCASE
FI872735A7 (en)	1987-12-21	New vaccines
DK524887A (en)	1988-04-14	CYCLONE
DK567786A (en)	1986-11-26	NON-ADJUSTIVE VACCINE
DK1987D0 (en)	1987-01-02	PREPARATION PROCEDURE PREPARATION PREPARATION
DK164491C (en)	1992-11-23	cyclone
DK467187D0 (en)	1987-09-08	Pseudorabies Virus vaccine
KR880021157U (en)	1988-12-23	Stacker
KR870008950U (en)	1987-06-15	Ceramic capacitor

Legal Events

Date	Code	Title	Description
1995-03-16	BB	Publication of examined application
1997-04-08	FD	Application lapsed
2004-08-31	MM	Patent lapsed	Owner name: ONCOGEN